Gam-COVID-Vac

GPTKB entity

Statements (69)
Predicate Object
gptkbp:instanceOf vaccine
gptkbp:administeredBy intramuscular injection
gptkbp:alsoKnownAs gptkb:Sputnik_V
gptkbp:approvedBy gptkb:Algeria
gptkb:Argentina
gptkb:Bahrain
gptkb:Belarus
gptkb:Bolivia
gptkb:Egypt
gptkb:Gabon
gptkb:Guatemala
gptkb:Hungary
gptkb:India
gptkb:Iran
gptkb:Jordan
gptkb:Kazakhstan
gptkb:Kyrgyzstan
gptkb:Laos
gptkb:Lebanon
gptkb:Mexico
gptkb:Moldova
gptkb:Mongolia
gptkb:Montenegro
gptkb:Morocco
gptkb:Nepal
gptkb:Nicaragua
gptkb:Pakistan
gptkb:Palestine
gptkb:Paraguay
gptkb:Philippines
gptkb:Russia
gptkb:San_Marino
gptkb:Serbia
gptkb:Sri_Lanka
gptkb:Syria
gptkb:Tunisia
gptkb:Turkey
gptkb:United_Arab_Emirates
gptkb:Uzbekistan
gptkb:Vanuatu
gptkb:Venezuela
gptkb:Vietnam
gptkb:Zimbabwe
gptkbp:category gptkb:COVID-19_vaccines
gptkb:COVID-19_pandemic_in_Russia
2020 introductions
Russian inventions
gptkbp:composition recombinant adenovirus vectors encoding SARS-CoV-2 spike protein
gptkbp:countryOfOrigin gptkb:Russia
gptkbp:developedBy gptkb:Gamaleya_Research_Institute
gptkbp:dosesRequired 2
gptkbp:effect 91.6% (published interim analysis)
gptkbp:firstRegistered 2020-08-11
https://www.w3.org/2000/01/rdf-schema#label Gam-COVID-Vac
gptkbp:intervalBetweenDoses 21 days
gptkbp:regimen heterologous prime-boost
gptkbp:sideEffect fever
fatigue
headache
mild flu-like symptoms
pain at injection site
gptkbp:storage 2–8°C
gptkbp:target gptkb:COVID-19
gptkbp:type viral vector vaccine
gptkbp:vectorUsed gptkb:adenovirus_serotype_26
adenovirus serotype 5
gptkbp:WHOStatus not approved by WHO as of 2024
gptkbp:bfsParent gptkb:Sputnik_V
gptkbp:bfsLayer 5